Cessation of Coverage

Align Research is terminating coverage on Oilex with immediate effect. Please note you should no longer rely on any previous research or estimates for this company. 


Align Research and a director of Align Research own shares in Oilex. Full details of our Company & Personal Account Dealing Policy can be found on our website http://www.alignresearch.co.uk/legal/

This is a marketing communication and cannot be considered independent research. Nothing in this report should be construed as advice, an offer, or the solicitation of an offer to buy or sell securities by us. As we have no knowledge of your individual situation and circumstances the investment(s) covered may not be suitable for you. You should not make any investment decision without consulting a fully qualified financial advisor.

Your capital is at risk by investing in securities and the income from them may fluctuate. Past performance is not necessarily a guide to future performance and forecasts are not a reliable indicator of future results. The marketability of some of the companies we cover is limited and you may have difficulty buying or selling in volume. Additionally, given the smaller capitalisation bias of our coverage, the companies we cover should be considered as high risk.

This financial promotion has been approved by Align Research Limited.

Table: financial overview
Year to Dec 2016A 2017A
Revenue (A$m) 0.45 0.09
Pre-tax profit (A$m) (36.15) (3.67)
EPS (c) (3.2) (0.3)
Source: Company accounts